Bacterial Infections
Welcome,         Profile    Billing    Logout  
 127 Companies   123 Products   123 Products   59 Mechanisms of Action   6 Trials   3245 News 


«12345678910111213...6566»
  • ||||||||||  niclosamide topical (ATx 201) / UNION Therap
    Trial completion:  Evaluation of ATx201 as a Topical Antibiotic Agent (clinicaltrials.gov) -  Mar 20, 2018   
    P1/2,  N=73, Completed, 
    Recruiting --> Completed
  • ||||||||||  Shanchol (oral cholera vaccine) / Sanofi
    Trial completion, Trial completion date, Trial primary completion date:  SCVB: Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh (clinicaltrials.gov) -  Mar 20, 2018   
    P3,  N=204438, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Jan 2016 --> Dec 2017 | Trial primary completion date: Jan 2016 --> Dec 2017
  • ||||||||||  Trial initiation date, Trial primary completion date:  Safety and Immunogenicity Study of GX-70 in TB Patient (clinicaltrials.gov) -  Mar 15, 2018   
    P1,  N=18, Not yet recruiting, 
    Recruiting --> Completed | Trial completion date: Jan 2016 --> Dec 2017 | Trial primary completion date: Jan 2016 --> Dec 2017 Initiation date: May 2017 --> Mar 2018 | Trial primary completion date: Mar 2018 --> Aug 2018
  • ||||||||||  Trial completion:  Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis (clinicaltrials.gov) -  Mar 8, 2018   
    P4,  N=50, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Mar 2018 | Trial primary completion date: Nov 2017 --> Feb 2018 Recruiting --> Completed
  • ||||||||||  mupirocin / Generic mfg.
    Trial completion, Trial completion date:  HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) -  Feb 28, 2018   
    P=N/A,  N=671, Completed, 
    Trial primary completion date: Jan 2018 --> Jun 2018 | Trial completion date: Mar 2018 --> Aug 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Nov 2017
  • ||||||||||  Minocin for injection (minocycline intravenous) / Melinta Therap
    Trial completion, Trial completion date, Trial primary completion date:  Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults (clinicaltrials.gov) -  Feb 22, 2018   
    P1,  N=61, Completed, 
    Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Nov 2017 Recruiting --> Completed | Trial completion date: Apr 2018 --> Feb 2018 | Trial primary completion date: Dec 2017 --> Feb 2018
  • ||||||||||  vancomycin / Generic mfg.
    Trial completion, Phase classification:  Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software (clinicaltrials.gov) -  Feb 20, 2018   
    P=N/A,  N=263, Completed, 
    Recruiting --> Completed | Trial completion date: Apr 2018 --> Feb 2018 | Trial primary completion date: Dec 2017 --> Feb 2018 Active, not recruiting --> Completed | Phase classification: P2 --> PN/A
  • ||||||||||  Trial completion date, Trial primary completion date, Biopsy:  COFFEE: Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy (clinicaltrials.gov) -  Feb 20, 2018   
    P=N/A,  N=50, Recruiting, 
    Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Trial primary completion date: Nov 2017 --> Mar 2018 | Trial completion date: Nov 2017 --> Mar 2018
  • ||||||||||  Menveo (meningococcal-groups A, C, W-135 and Y oligosaccharide CRM197 conjugate vaccine) / GSK
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date:  Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea (clinicaltrials.gov) -  Feb 19, 2018   
    P4,  N=3948, Completed, 
    Trial primary completion date: Nov 2017 --> Mar 2018 | Trial completion date: Nov 2017 --> Mar 2018 Recruiting --> Completed | Trial completion date: Feb 2018 --> Jan 2018 | Initiation date: Mar 2013 --> Mar 2013 | Trial primary completion date: Feb 2018 --> Jan 2018
  • ||||||||||  Trial completion:  Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae (clinicaltrials.gov) -  Feb 14, 2018   
    P=N/A,  N=60, Completed, 
    Recruiting --> Completed | Trial completion date: Feb 2018 --> Jan 2018 | Initiation date: Mar 2013 --> Mar 2013 | Trial primary completion date: Feb 2018 --> Jan 2018 Recruiting --> Completed
  • ||||||||||  Enrollment change, Trial withdrawal, HEOR:  Impact of Rapid Detection of MRSA (clinicaltrials.gov) -  Feb 13, 2018   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Completed N=240 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  ciprofloxacin oral / Generic mfg.
    Trial completion, Trial completion date:  Ciprofloxacin for the Prevention of Meningococcal Meningitis (clinicaltrials.gov) -  Feb 8, 2018   
    P4,  N=300, Completed, 
    Initiation date: Apr 2013 --> Jul 2013 | Completed --> Terminated; The study was stopped early due to feasibility concerns. Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017
  • ||||||||||  rifampicin / Generic mfg.
    Trial completion, Trial completion date:  Accuracy and Feasibility of Xpert Ultra (clinicaltrials.gov) -  Feb 8, 2018   
    P=N/A,  N=1400, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017 Recruiting --> Completed | Trial completion date: Mar 2017 --> Oct 2017
  • ||||||||||  vancomycin / Generic mfg.
    Trial completion date, Trial primary completion date:  RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates (clinicaltrials.gov) -  Feb 6, 2018   
    P=N/A,  N=200, Recruiting, 
    N=1634 --> 992 Trial primary completion date: Dec 2017 --> Dec 2018 | Trial completion date: Dec 2017 --> Dec 2018
  • ||||||||||  Trial completion date, Trial initiation date, Trial primary completion date, HEOR, Real-world evidence, Real-world:  Effect of Xpert MTB/RIF on Patient Outcomes (clinicaltrials.gov) -  Feb 5, 2018   
    P=N/A,  N=892, Active, not recruiting, 
    Trial primary completion date: Dec 2017 --> Dec 2018 | Trial completion date: Dec 2017 --> Dec 2018 Initiation date: Jan 2016 --> Jun 2016 | Trial primary completion date: Aug 2017 --> Feb 2018 | Trial completion date: Dec 2017 --> Dec 2018
  • ||||||||||  apremilast / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  SMASH: Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis (clinicaltrials.gov) -  Feb 5, 2018   
    P2,  N=20, Completed, 
    Initiation date: Jan 2016 --> Jun 2016 | Trial primary completion date: Aug 2017 --> Feb 2018 | Trial completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Dec 2017
  • ||||||||||  Cubicin (daptomycin) / Merck (MSD)
    Trial completion, Enrollment change:  IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB (clinicaltrials.gov) -  Feb 1, 2018   
    P4,  N=40, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Dec 2017 Recruiting --> Completed | N=50 --> 40
  • ||||||||||  Enrollment change, Trial primary completion date:  Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects (clinicaltrials.gov) -  Feb 1, 2018   
    P=N/A,  N=20, Recruiting, 
    Not yet recruiting --> Completed | N=1250 --> 810 | Trial primary completion date: Feb 2017 --> Nov 2017 N=100 --> 20 | Trial primary completion date: Dec 2017 --> Mar 2018
  • ||||||||||  Trial completion, IO biomarker:  Multi-Drug Resistant Tuberculosis in Korea (clinicaltrials.gov) -  Jan 31, 2018   
    P=N/A,  N=2040, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  levofloxacin / Generic mfg.
    Trial completion, Trial primary completion date:  PK of Levofloxacin in MDR-TB Patients (clinicaltrials.gov) -  Jan 25, 2018   
    P=N/A,  N=20, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2017
  • ||||||||||  Trial primary completion date:  Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs (clinicaltrials.gov) -  Jan 18, 2018   
    P=N/A,  N=25, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: May 2017 --> Mar 2018
  • ||||||||||  niclosamide topical (ATx 201) / UNION Therap
    Trial primary completion date:  Evaluation of ATx201 as a Topical Antibiotic Agent (clinicaltrials.gov) -  Jan 17, 2018   
    P1/2,  N=76, Recruiting, 
    N=300 --> 218 | Recruiting --> Terminated; Sponsor lack of funding Trial primary completion date: Nov 2017 --> Feb 2018
  • ||||||||||  GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
    Trial completion, P1 data:  A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (clinicaltrials.gov) -  Dec 28, 2017   
    P1,  N=36, Completed, 
    Trial primary completion date: Mar 2017 --> Mar 2018 Active, not recruiting --> Completed
  • ||||||||||  RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD), Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
    Trial primary completion date:  A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (clinicaltrials.gov) -  Dec 26, 2017   
    P3,  N=2808, Completed, 
    Active, not recruiting --> Completed Trial primary completion date: Jul 2013 --> Dec 2012
  • ||||||||||  Trial completion:  TDAP Safety in Pregnant Women (clinicaltrials.gov) -  Dec 20, 2017   
    P=N/A,  N=375, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed